| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.29 | 6e-08 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.29 | 2e-07 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.28 | 2e-06 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.25 | 6e-06 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.13 | 9e-05 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.2 | 0.0005 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.2 | 0.0007 |